Can I get vaccinated during Pancreatic Cancer treatment

Pancreatic Cancer Vaccines During Treatment: What You Should Know

This is an excellent question, and the answer involves understanding how therapeutic cancer vaccines work differently than traditional vaccines you might be familiar with.

The Current State of Pancreatic Cancer Vaccines

According to recent clinical research, therapeutic cancer vaccines for pancreatic cancer are being tested primarily AFTER surgery and standard chemotherapy, rather than during active treatment. Here's what the evidence shows:

Timing in Treatment Plans

During Active Chemotherapy: The vaccines being studied are generally given after you've completed your standard chemotherapy regimen (like mFOLFIRINOX), not simultaneously. This is because:

• Your immune system needs to recover enough to mount an effective response to the vaccine
• Chemotherapy can suppress immune function, which might reduce the vaccine's effectiveness
• Researchers want to measure the vaccine's impact clearly without interference from other treatments

After Surgery and Chemotherapy: According to Let's Win Pancreatic Cancer resources, most current trials enroll patients who have:

1. Undergone surgery to remove the tumor
2. Completed post-surgical chemotherapy or radiation
3. Have no evidence of remaining disease

Then the vaccine is administered as an additional treatment to help prevent recurrence.

How These Vaccines Work

Pancreatic cancer vaccines being tested use personalized approaches:

• Neoantigens (new proteins created by your specific cancer cells) are identified from your tumor
• [ID removed] technology teaches your immune system to recognize these cancer-specific proteins
• Mesothelin epitopes (parts of proteins highly expressed in pancreatic cancer) are included to boost the immune response
• The goal is to activate your T cells—immune cells that can hunt down and destroy remaining cancer cells

According to CancerPatientLab's 2024 webinar on "Novel Therapies and New Directions in Pancreas Cancer," early studies showed that in 8 of 16 patients studied, the vaccines successfully activated T cells that recognized their own pancreatic cancer, with some patients showing delayed recurrence.

Important Questions to Ask Your Oncology Team

Since vaccine approaches are evolving, here are specific questions for your healthcare team:

1. "Are there any clinical trials for pancreatic cancer vaccines that I might be eligible for?" (ClinicalTrials.gov and Let's Win Trial Finder are good resources to explore together)

2. "If I'm currently in chemotherapy, when would be the best time to discuss vaccine options—now or after treatment?"

3. "What type of vaccine approach would be most appropriate for my specific cancer profile?" (personalized neoantigen vs. off-the-shelf KRAS-targeted vaccines)

4. "What immune monitoring will be done to see if the vaccine is working?" (blood tests to check T cell activation)

5. "What are the potential side effects, and how do they compare to my current treatment?"

Current Research Status

According to Dr. [removed] O'Reilly's presentation at ASCO GI 2024, vaccine trials are showing "early signals" of benefit, but these are still largely in clinical trial settings. The field is moving toward:

• Personalized [ID removed] vaccines (customized to your tumor's mutations)
• KRAS-targeted vaccines (an off-the-shelf option targeting the most common pancreatic cancer mutation)
• Combination approaches (vaccines combined with other immunotherapies like checkpoint inhibitors)

The Bottom Line

You likely cannot receive these vaccines during active chemotherapy, but they may be an option after you complete standard treatment. The timing and type would depend on:

• Your specific treatment plan
• Your cancer's genetic profile
• Your overall health and immune function
• Whether you're eligible for a clinical trial

This is a rapidly evolving field—what wasn't available a year ago may be available now, so it's worth having this conversation with your oncology team.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.